Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive entities : Lantern pharma inc. save search
Lantern Pharma Announces Positive New Data for its Drug Candidate LP-284 for Mantle Cell Lymphoma (MCL) at the American Society of Hematology (ASH) 2022 Annual Meeting
Published: 2022-12-15 (Crawled : 14:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: 2.04%
H: 1.81%
C: -0.91%
lp-284 pharma drug candidate meeting positive
Lantern Pharma Announces Positive Data Highlighting the Anti-Tumor Potency of Drug Candidate LP-184 for Glioblastoma at the Society for Neuro-Oncology Annual Meeting
Published: 2022-11-22 (Crawled : 14:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: 3.37%
H: 5.18%
C: -1.92%
lp-184 pharma drug candidate meeting positive glioblastoma
Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting
Published: 2022-09-23 (Crawled : 13:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: -0.84%
H: 1.7%
C: 0.64%
lp-284 pharma preclinical meeting positive
Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer
Published: 2022-09-14 (Crawled : 13:20) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: 1.57%
H: 8.91%
C: 3.88%
lp-184 pharma conference preclinical positive cancer pancreatic
Lantern Pharma to Present Positive Preclinical Data on the Effectiveness of LP-184 in Brain Metastases at the American Association of Cancer Research (AACR) Annual Meeting
Published: 2022-03-14 (Crawled : 14:30) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: -9.16%
lp-184 america pos research preclinical positive cancer pre-clinical train brain metastases
Lantern Pharma Presents Positive Data on the Effectiveness of LP-284 in Hematologic Cancers at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-14 (Crawled : 20:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: 0.13%
H: 1.57%
C: -1.77%
lp-284 ema positive cancer
Lantern Pharma Announces Positive Preclinical Data in Glioblastoma (GBM) with Drug Candidate LP-184 and Expands GBM Research Collaboration
Published: 2021-08-19 (Crawled : 13:00) - prnewswire.com
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: -2.4%
H: 0.0%
C: -3.07%
positive collaboration drug research preclinical pre-clinical glioblastoma
Lantern Pharma Announces Significant Positive Preclinical Data in Pancreatic Cancer With Drug Candidate LP-184
Published: 2021-07-20 (Crawled : 12:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: 2.35%
H: 15.03%
C: 14.49%
positive cancer drug pancreatic pancreas preclinical pre-clinical pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.